Zobrazeno 1 - 10
of 233
pro vyhledávání: '"Vedat Hamuryudan"'
Autor:
Didar Ucar, Burak Mergen, Busenur Gonen, Yesim Ozguler, Emire Seyahi, Vedat Hamuryudan, Yilmaz Ozyazgan
Publikováno v:
Indian Journal of Ophthalmology, Vol 68, Iss 9, Pp 1876-1880 (2020)
Purpose: To compare the long-term results of the patients with branch retinal vein occlusion (BRVO) secondary to Behçet's syndrome (BS) with the patients with unknown etiology. Methods: Medical records and optical coherence tomography (OCT) imaging
Externí odkaz:
https://doaj.org/article/f5f7f581ed354c09bde2a5dfff00ad8e
Autor:
Sinem Nihal Esatoglu, Koray Tascilar, Hakan Babaoğlu, Cemal Bes, Berna Yurttas, Servet Akar, Ozlem Pehlivan, Cansu Akleylek, Duygu Tecer, Emire Seyahi, Tuba Yuce-Inel, Nilufer Alpay-Kanitez, Erdal Bodakci, Emre Tekgoz, Seda Colak, Ertugrul Cagri Bolek, Suleyman Serdar Koca, Umut Kalyoncu, Ozan Cemal Icacan, Serdal Ugurlu, Hande Ece Oz, Vedat Hamuryudan, Gulen Hatemi, the Turkish Society for Rheumatology COVID-19 Registry Investigators, Ayse Cefle, Ali Karakas, Derya Kaskari, Samet Karahan, Dilek Tezcan, Abdurrahman Tufan, Ayse Ayan, Levent Kılıc, Salim Donmez, Mustafa Erdogan, Veli Yazisiz, Edip Gokalp Gok, Ahmet Eftal Yucel, Elif Dincses Nas, Gezmiş Kimyon, Gunay Sahin Dalgic, Hakan Erdem, Kerem Yigit Abacar, Ridvan Mercan, Omer Karadag, Onay Gercik, Suleyman Ozbek, Sebnem Gider, Semih Gulle, Sibel Osken, Sedat Kiraz, Timucin Kasifoglu, Fatma Alibaz-Oner, Izzet Fresko, Ali Akdogan, Neslihan Yilmaz
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundThe course of novel coronavirus disease 2019 (COVID-19) has been of special concern in patients with inflammatory rheumatic diseases (IRDs) due to the immune dysregulation that may be associated with these diseases and the medications used
Externí odkaz:
https://doaj.org/article/4de36d4dba664dd2ae34873a6dca683e
Autor:
Sinem Nihal Esatoglu, Fatma Nihan Akkoc-Mustafayev, Yesim Ozguler, Fatma Ozbakır, Okan K. Nohut, Dilsen Cevirgen, Vedat Hamuryudan, Ibrahim Hatemi, Aykut Ferhat Celik, Hasan Yazici, Gulen Hatemi
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
BackgroundImmunogenicity of tumor necrosis factor alpha inhibitors (TNFis) has been recognized as an important problem that may cause loss of efficacy and adverse events such as infusion reactions. TNFis are being increasingly used among patients wit
Externí odkaz:
https://doaj.org/article/1b84734452af406395e02aad982f0ced
Publikováno v:
Kidney & Blood Pressure Research, Vol 42, Iss 6, Pp 1322-1337 (2017)
Background/Aims: MiRNAs transpire as promising elements in molecular medicine for the identification of new diagnostic, prognostic and targeting therapeutic biomarkers. This study consisted of four steps: First, to investigate one or a group of speci
Externí odkaz:
https://doaj.org/article/6a7efd12b1964e50a588e60576fad30e
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-8 (2017)
Abstract Background There is no established treatment of AA amyloidosis, a long-term complication of various chronic inflammatory diseases associated with increased mortality, such as familial Mediterranian fever (FMF). Recently there are few reports
Externí odkaz:
https://doaj.org/article/3bcdd3f0cbe74b8abceac428cc6c3fb7
Publikováno v:
Ulusal Romatoloji Dergisi. 15:25-29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a934ac9999c0b8c493b521d579bac0d3
https://doi.org/10.4274/raed.galenos.2023.46036
https://doi.org/10.4274/raed.galenos.2023.46036
Autor:
Yeşim Özgüler, Tümay Ak, Sinem Nihal Esatoğlu, Tuğrul Elverdi, Ahmet Emre Eşkazan, Serdal Uğurlu, Gülen Hatemi, Emire Seyahi, Melike Melikoğlu, İzzet Fresko, Muhlis Cem Ar, Vedat Hamuryudan
Publikováno v:
Ulusal Romatoloji Dergisi. 14:131-136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a74ab9494b98b76ff0ae3d87c25c3eb
https://doi.org/10.4274/raed.galenos.2022.09719
https://doi.org/10.4274/raed.galenos.2022.09719
Autor:
Guzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, Yesim Ozguler, Sebahattin Yurdakul, Vedat Hamuryudan, Izzet Fresko, Melike Melikoglu, Emire Seyahi, Serdal Ugurlu, Huri Ozdogan, Hasan Yazici, Gulen Hatemi
Publikováno v:
Rheumatology. 62:9-18
Objective A decline in the frequency of AA amyloidosis secondary to RA and infectious diseases has been reported. We aimed to determine the change in the frequency of AA amyloidosis in our Behçet’s syndrome (BS) patients and to summarize the clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81baf669a5d117f4f1f8b3b918a633e3
https://doi.org/10.1093/rheumatology/keac223
https://doi.org/10.1093/rheumatology/keac223
Publikováno v:
A Clinician's Pearls & Myths in Rheumatology ISBN: 9783031234873
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2640a90ad9e13c12e2e84e4e6f90b90e
https://doi.org/10.1007/978-3-031-23488-0_20
https://doi.org/10.1007/978-3-031-23488-0_20
Autor:
Vedat Hamuryudan, Izzet Fresko, Sinem Nihal Esatoglu, Yesim Ozguler, Serdal Ugurlu, Melike Melikoglu, Sebahattin Yurdakul, H Gul Ongen, A Hacioglu, Gulen Hatemi, Emire Seyahi, Aykut Ferhat Celik, Ibrahim Hatemi, Huri Ozdogan, Sermin Borekci
Publikováno v:
Rheumatology International. 42:1443-1451
It is assumed that in candidates for TNF-alpha inhibitor (TNFi) treatment, tuberculin skin test (TST) may be unreliable, since BCG vaccination causes false positive and drugs cause false negative results, favoring the use of Quantiferon or T-spot ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::885e31edf8f3c10064a2bbe522913bf6
https://doi.org/10.1007/s00296-021-04926-z
https://doi.org/10.1007/s00296-021-04926-z